About Matthew Cooper
Matthew Cooper is CEO & Co-founder, director at Enumera Molecular.
Matthew Cooper first appears on SEC filings in 2022.
Experience
This experience comes from Matthew Cooper's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Cooper in the role, so the role may have started earlier or lasted longer.
Enumera Molecular, Inc. Current
CEO & Co-founder, director
Chief Executive Officer (2022 – Present)
2022 – Present · Ann Arbor, MI
Develops a molecular testing platform for commercial and hospital laboratories.
AI
Avails Medical, Inc. Current
Board Member
2019 – Present
ST
StartX. Current
Adviser & Mentor
2013 – Present
NE
NeoSeq
Board Member
2018 – 2022
PI
Progenity, Inc.
General Manager, Diagnostics
2015 – 2022
PF
Preeclampsia Foundation
Board Member
2014 – 2020
SM
Stanford University School of Medicine
Advisor at SPARK Translational Research Program
2011 – 2019
UC
UCSF
Advisor and Mentor to Lean LaunchPad for Life Sciences & Healthcare
2013 – 2018
CB
Carmenta Bioscience
CEO and Founder
2012 – 2015
SI
Syapse Inc.
Chief Science Officer
2010 – 2012
HR
Hoffmann-La Roche
Head of Non-Clinical Safety Information
2009 – 2010
RA
Roche Palo Alto
Principal Research Scientist
2006 – 2009
BI
Biogen Idec
Scientist II
2001 – 2006
ML
Merrill Lynch
Summer Intern
1999
DC
Dow Corning
Summer Intern
1997
PG
Procter & Gamble
Summer Intern
1996
Key Colleagues at Startups
The people Matthew Cooper works with at each company, as listed on that company's latest Form D.
Enumera Molecular, Inc. · Form D, Jul 31, 2026
DK
Dan Kidle
Managing Partner, Arboretum Ventures and director
EH
Elaine Heron
Board Member
SB
Sundaresh Brahmasandra
Board Member